Page last updated: 2024-11-05

urapidil and Active Hyperemia

urapidil has been researched along with Active Hyperemia in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Fractional flow reserve (FFR, calculated by coronary pressure measurements during adenosine-induced hyperaemia) was assessed in 85 patients with an intermediate coronary stenosis (mean diameter stenosis of 50+/-1%) and normal left ventricular function which were divided into the following three groups: (a) 33 patients before and after IC bolus of phentolamine, an alpha1-, alpha2-adrenergic blocker; (b) 32 patients before and after IC bolus of urapidil, a selective alpha1-adrenergic blocker; (c) 20 patients before and after IC bolus of saline."3.72Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses. ( Aarnoudse, W; Barbato, E; Bartunek, J; De Bruyne, B; Heyndrickx, GR; Pijls, NH; Staelens, F; Vanderheyden, M; Wijns, W, 2004)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Barbato, E1
Bartunek, J1
Aarnoudse, W1
Vanderheyden, M1
Staelens, F1
Wijns, W1
Heyndrickx, GR1
Pijls, NH1
De Bruyne, B1

Other Studies

1 other study available for urapidil and Active Hyperemia

ArticleYear
Alpha-adrenergic receptor blockade and hyperaemic response in patients with intermediate coronary stenoses.
    European heart journal, 2004, Volume: 25, Issue:22

    Topics: Adrenergic alpha-Antagonists; Blood Pressure; Coronary Artery Disease; Coronary Circulation; Coronar

2004